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CONSTITUTIVE EXPRESSION OF HIGH AFFINITY
INTERLEUKIN 2 RECEPTORS ON HUMAN CD16 -
NATURAL KILLER CELLS IN VIVO
By ARNON NAGLER, LEWIS L . LANIER, AND JOSEPH H. PHILLIPS
From the Becton Dickinson Monoclonal Center, Inc., San Jose, California 95131
IL-2, a lymphokine secreted by T cells that functions in the growth and differenti-
ation of lymphocytes and monocytes, binds to a 55-kD glycoprotein (p55), desig-
nated CD25, with low affinity (N10-40 nM kD) and a 70-75 kD glycoprotein (p75)
with an intermediate affinity (-1-5 nM kD) (1-4) . The high affinity IL-2 receptor
(-10-30 pM kD) is composed of noncovalently associated p55 and p75 subunits
(1-4) . Several laboratories have generated mAbs against the p55 and p75 IL-2 binding
proteins (5, 6), thus allowing for the detection of these receptors on leukocyte popu-
lations .
NK cells are a distinct population of CD3e -,CD56 + lymphocytes that do not rear-
range or express TCR genes and are characterized by their ability to mediate MHC-
unrestricted cytotoxicity against a variety of tumor- and virus-infected cell lines (7) .
IL-2 directly activates NK cells, resulting in proliferation and the induction of cyto-
toxic activity (8-10) . The majority of peripheral blood CD16+ NK cells constitu-
tively express the p75 IL-2R, and mAbs against p75 IL-2R efficiently block IL-2-
dependent functions, suggesting that the p75 IL-2R is the predominant IL-2 binding
structure on resting NK cells (11) . We have previously reported that two subsets of
NK cells can be identified based on expression of CD16 (FcR-yIII) . Whereas most
peripheral blood NK cells express the phenotype CD16+,CD56 + , a minor subset of
NK cells are CD16- ,CD56+ (referred to as CD16 - NK cells) (12, 13) . Neither of
these subsets expresses CD3e or rearranges TCR genes, but both mediate NK cyto-
toxic function and express many similar phenotypic characteristics (12, 13) . In the
present study, we demonstrate that CD16- NK cells constitutively express high
affinity IL-2 receptors in vivo and preferentially respond to low amounts of IL-2 .
Materials and Methods
Cell Purification andCulture.
	
PBMC were isolated by Ficoll/Hypaque centrifugation . After
plastic adherence and passage through nylon wool, NK cells were enriched by centrifugation
on discontinuous gradients ofPercoll (Pharmacia Fine Chemicals, Piscataway, NJ) (10) . Cells
were cultured in RPMI 1640 media (M. A . Bioproducts, Walkersville, MD) supplemented
with 4% horse serum (KC Biologicals, Lenexa, KS), 1 MM L-glutamine (Gibco Laborato-
ries, Grand Island, NY), and antibiotics . rIL-2 (18 x 10 6 IU/mg) was generously provided
by Cetus Corp., Emeryville, CA. For proliferation assays, cells were incubated in 96-well cul-
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ture plates and harvested after 4 d following an overnight pulse with ( 3H]thymidine (1
pCi/well ; Amersham Corp., Arlington Heights, IL) .
Monoclonal Antibodies. TU27 mAb (generously provided by Dr. K . Sugamura, Tohoku
University School ofMedicine, Sendai, Japan) reacts with the p75 IL-2R and inhibits binding
of IL-2 to this receptor (5) . Leu series mAbs and anti-CD25 (clone 2A3) were produced by
Becton Dickinson Monoclonal Center, Inc . (Mountain View, CA) . Phycoerythrin (PE)-
conjugated TU27 and anti-CD25 mAbs were generously provided by Dr. A . Jackson and
Mr. A . Blidy, Becton Dickinson Monoclonal Center.
Immunofluorescence and Flow Cytometry . Immunofluorescence and flow cytometry were per-
formed as previously described (10) . Cells were analyzed on a FACScan, and cell sorting was
performed on a FACStar or FAGS IV (Becton Dickinson Immunocytometry Systems, San
Jose, CA) .
Cytotoxicity Assay. Cell-mediated cytotoxicity was measured in a 4-h "Cr-release assay (10) .
IL-2 Binding Assay. IL-2 binding assays and Scatchard analysis were performed as previ-
ously described (14) . All reagents for the binding assays were generously provided by Dr.
Kendall Smith (Dartmouth Medical School, Hanover, NH).
Results and Discussion
Expression ofp75 and p55 IL-2 Receptors on CD16- and CD16' NK Cells . PBL en-
riched for NK cells using Percoll density gradients were stained with FITC anti-
CD56 and PE anti-CD25 or PE anti-p75 IL-2R and analyzed by two-color im-
munofluorescence . As previously reported (12), the majority of circulating resting
NK cells express low surface density CD56 and high surface density CD16 (CD16+
CD56d'°" NK cells) . A small subset of NK cells do not express CD16, but have
significantly higher surface density CD56 (CD16-CD56b"ght' NK cells) . Neither of
these NK cell subsets express CD3 (12) . Based on analysis of more than 20 normal
donors, both CD16- CD56br'gh' and CD16+CD56d""+ NK cell subsets expressed the
p75 IL-2R ; however, only the CD16-CD56br'ghc+ NK cells constitutively expressed
detectable CD25 (Fig . 1) . The finding that the major subset of NK cells (CD16+-
CD56d'm+) express only the p75 IL-2R and mediate IL-2-dependent functions pri-
marily through an intermediate affinity receptor is consistent with prior reports (1-4,
11) . Co-expression of CD25 and p75 IL-2R on the CD16-CD56b°gh'+ NK cells sug-
gested that these cells possess high affinity IL-2 receptors .
Differential response of CD16- and CD16' NK Cells to Low Concentrations of rIL-2 .
CD16- and CD16' NK cells were isolated to >98% purity by cell sorting, incubated
with various concentrations of rIL-2, and assayed for cytolytic activation and IL-2-
dependent proliferation (Fig. 2) . Consistent with the presence of high affinity IL-2
receptors, CD16 - NK cells showed a significantly greater magnitude of IL-2-
induced cytolytic activation and proliferation than CD16' NK cells . CD16- NK cells
demonstrated potent cytolytic activation and proliferation at IL-2 concentrations
as low as 9 IU/ml . CD16' NK cells required significantly higher concentrations of
IL-2, consistent with intermediate affinity IL-2 receptors being the primary IL-2
signal-transducing structure on these cells .
IL-2 BindingAssays . IL-2 binding assays were performed to determine the number
and affinity of the IL-2 receptors . Scatchard analysis demonstrated the presence of
-1,200 high affinity (-25 pM kD) and -9,600 intermediate affinity (-2 nM kD)
IL-2 receptors on CD16" NK cells (Fig. 3) . CD16' NK cells expressed only a single
intermediate affinity IL-2 receptor of -1.9 nM kD (-9,000 sites per cell) . The IL-2
binding data thus substantiated the phenotypic and functional studies and defini-
NAGLER ET AL.
	
1529
FIGURE 1 . Expression ofIL-2 receptors on NK cell subsets .
PBL enriched for NK cells were stained with FITC-con-
jugated IgM control mAbs and PE-conjugated IgGi con-
trol mAb (A) or FITC-conjugated anti-CD56 (clone L185)
and PE-conjugated anti-p75 IL-2R (TU27; B) or FITC-
conjugated anti-CD56 and PE-conjugated anti-CD25 (clone
2A3; C). Flowcytometric data are presented as contour plots
(xandy axes are4-decade logscales). Markers defining quad-
rants were positioned to include >98% of unstained cells
in lower left quadrant .
tively showed that the differential responsiveness of CD16- and CD16' NK cells to
IL-2 is manifested through different affinity IL-2 receptors .
Effects of Anti-IL-2 Receptor mAbs on IL-2-dependent Functions. Experiments were
undertaken to determine the effects ofblocking mAbs against p75 IL-2R andCD25
on IL-2-dependent functions of CD16 - and CD16+ NK cell subsets . As previously
reported (11), mAbs against p75 IL-2R effectively blocked IL-2 activation ofCD16+
NK cells (Fig. 4, A, B) . Interestingly, although anti-CD25 mAbalone failed to affect
IL-2-induced activation (as would be expected from the phenotypic and binding
studies), anti-CD25 mAb slightly increased the inhibition observed with anti-p75
IL-2R mAb(Fig . 4, A, B) . These results suggest that functional high affinity receptors
may be present in very low levels (undetectable by IL-2 binding assays or flow cytom-
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FIGURE 2 . Effects of IL-2 concentration on
activation andproliferation of NK cell subsets .
CD16'CD56d- (/) and CD16-CD566r'gh,
(®) NK cells were sorted to >98% purity, in-
cubated with various concentrations of IL-2
(IU/ml x 10 - ') overnight, and assayed for
cytotoxicity against the NK cell-resistant
tumor cell line Colo-205 at an E/T ratio of
25 :1 (A) . Resting NK cell subsets do not lyse
Colo-205 (10) . For proliferation assays (B, C),
cells were plated at 5 x 106 cells/ml (B) or
5 x 10 4 cells/ml (C in the presence of var-
ious concentrations of IL-2 . Proliferation was
assessed by ['Hlthymidine incorporation
after 4 d in culture .
etry) on these cells and that neutralization requires the presence of both anti-p75
IL-2R and anti-CD25 mAb.
IL-2-induced cytolytic activation of CD16- NK cells was inhibited by the anti-
p75 IL-2R mAb, but not by anti-CD25 mAb (Fig . 4 A) . A combination of both
anti-p75 IL-2R and anti-CD25 mAbs was more effective than anti-p75 IL-2RmAb
alone in inhibiting cytolytic activation . Surprisingly, neither anti-p75 IL-2R nor anti-
CD25 mAb alone affected IL-2-dependent proliferation ofCD16- NK cells, whereas
acombination ofboth mAb gave pronounced inhibition (Fig . 4 C) . Previous studies
have shown that these mAbs against CD25 and p75 IL-2R are effective in inhibiting
binding of IL-2 to the high affinity receptor (5). Since CD16- NK cells express high
affinity IL-2 receptors presumably consisting of a p75/p55 complex, it was surprising
that high concentrations (20-30 ug/ml) ofthese mAbs individually had no significant
effect on IL-2-induced proliferation. Similar results have recently been reported for
mAb blocking of IL-2-dependent proliferation of T cell lines expressing both inter-
mediate and high affinity IL-2 receptors (5, 6) . Relative affinity andbinding kinetics
of the mAb versus ligand may account for these results.
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A. CD16-Negative NK cells.
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B. CD16-positive NK cells
0
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FIGURE 3. Binding of 1 125 1JIL-2 to NK cell subsets. Peripheral blood CD16 - (A) and CD16`
(B) NK cells, isolated to >98% purity, were incubated with serial various concentrations of 1211-
labeled IL-2 for 45 min at 37°C (2 x 105 cells/determination) and then centrifuged through a
cushion of oil to separate bound from unbound IL-2 (14) . Nonspecific binding was determined
in the presence of 200 molar excess of unlabeled IL-2 . Data are represented as Scatchard plots.
Recently, it has been shown that a substantial proportion of peripheral blood
CD4 + T lymphocytes express low levels of CD25 (15) ; however, these T cells usu-
ally express only low affinity IL-2 receptors, lack p75 IL-2R, and are unresponsive
to IL-2 (5, 6, 11, and Phillips, J . H., unpublished observation) . Therefore, the
CD16- NK cell subset represents the only consistently detectable population of lym-
phocytes in peripheral blood ofnormal adults that constitutively expresses high affinity
IL-2 receptors in vivo. Based on an extensive study of these cells, we have suggested
that CD16 - NK cells may represent a peripheral blood progenitor population for
mature CD16+ NK cells (13) . If this is the case, the presence of high affinity IL-2
receptors may allow expansion and differentiation of these cells with physiological
concentrations of IL-2 . Alternatively, CD16 - NK cells may represent a distinct NK
subset that constitutively expresses high affinity IL-2 receptors as a consequence of
activation in vivo . Nonetheless, the presence of high affinity IL-2 receptors would
permit preferential responsiveness of CD16- NK cells in patients treated with rIL-2
for therapeutic purposes . Recent studies have shown a pronounced expansion of the
CD16- NK cell subset in the peripheral blood of cancer patients after in vivo rIL-2
therapy (16, 17) . During normal immune responses, CD16- NK cells may respond
to IL-2 produced in vivo by T cells after antigenic stimulation . CD16- NK cells
have been shown to transcribe TNF-a and granulocyte/macrophage CSF (GM-CSF)
after activation with IL-2 in vitro (13) . If this occurs in vivo, these cells may be an
important source of cytokine production in physiological situations .
Summary
The majority of human NK cells express low affinity IgG Fc receptors (CD16+),
whereas a minor subset of NK cells lack Fc receptor expression (CD16 - ) . In con-
trast to CD16 + NK cells that express only p75 IL-2 receptors, CD16- NK cells con-
stitutively co-express both p75 and p55 IL-2 receptors in vivo and preferentially
respond to low concentrations ofIL-2 with increased cytolytic activation and prolifer-
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FIGURE 4 . Effects of anti-IL-2R mAbs on
IL-2-induced cytotoxicity and proliferation .
CD16' (/) and CD16 - (®) NK cell subsets
were isolated to >98% purity by cell sorting
and incubated with # IU/rnl rIL-2 in the pres-
ence or absence of control (Co)or neutralizing
anti-p75 and/or p55 (CD25) IL-2R mAb
(30 Wg/ml), as indicated . Cells were harvested
after overnight culture for cytotoxicity assays
(target # Colo-205 ; E/T ratio, 25:1) . Prolifer-
ation was assessed by [ ;H]thymidine incor-
poration after 4 d in culture .
ation. Scatchard analysis demonstrated the presence of -1,200 high affinity (-25
pM kD) and -9,600 intermediate affinity (-2 nM kD) IL-2 receptors on CD16-
NK cells . CD16' NK cells expressed only a single intermediate affinity IL-2
receptor of -1 .9 nM kD (-9,000 sites per cell) . The IL-2 binding data thus sub-
stantiated the phenotypic and functional studies and definitively show that the differen-
tial responsiveness of CD16 - and CD16' NK cells to IL-2 is manifested through
different affinity IL-2 receptors.
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